BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 7013437)

  • 41. Levamisole: as adjuvant to cyclic chemotherapy in breast cancer.
    Stephens EJ; Wood HF; Mason B
    Recent Results Cancer Res; 1978; 68():139-45. PubMed ID: 379932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Chemotherapic management of genitomammary tumors].
    Sarría JA; Irigoyen ML; Cismondi B
    Rev Fac Cien Med Univ Nac Cordoba; 1981; 39(1-4):3-16. PubMed ID: 6897122
    [No Abstract]   [Full Text] [Related]  

  • 43. The use of mitoxantrone in the treatment of breast cancer.
    Hainsworth JD
    Semin Oncol; 1995 Feb; 22(1 Suppl 1):17-20. PubMed ID: 7863347
    [No Abstract]   [Full Text] [Related]  

  • 44. Effectiveness of intermediate-dose methotrexate and high-dose 5-fluorouracil as sequential combination chemotherapy in refractory breast cancer and as primary therapy in metastatic adenocarcinoma of the colon.
    Tisman G; Wu SJ
    Cancer Treat Rep; 1980; 64(8-9):829-35. PubMed ID: 7448820
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adriamycin combinations in advanced breast cancer. A Southwest Oncology Group Study.
    Tranum BL; McDonald B; Thigpen T; Vaughn C; Wilson H; Maloney T; Costanzi J; Bickers J; el Mawli NG; Palmer R; Hoogstraten B; Heilburn L; Rasmusen S
    Cancer; 1982 Mar; 49(5):835-9. PubMed ID: 7037152
    [No Abstract]   [Full Text] [Related]  

  • 46. [Adriamycin/cyclophosphamide: current standard in the adjuvant therapy of breast carcinoma? Or: how should one really put this question?].
    Cavalli F
    Schweiz Med Wochenschr; 1994 Oct; 124(43):1882-4. PubMed ID: 7973514
    [No Abstract]   [Full Text] [Related]  

  • 47. Adjuvant therapy of stage II, III breast cancer.
    Buzdar AV; Gutterman JU; Blumenschein GR; Tashima CK; Hortobágyi GN; Yap HY; Hersh EM; Gehan EA
    Recent Results Cancer Res; 1978; 68():123-8. PubMed ID: 379930
    [No Abstract]   [Full Text] [Related]  

  • 48. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of "split" courses of combination chemotherapy in breast cancer].
    Dymarskiĭ LIu; Aleksandrova GI; Sanchakova AV
    Vopr Onkol; 1981; 27(7):82-5. PubMed ID: 7269435
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Five-drug therapy in addition to hormonal treatment in advance breast cancer metastatic to the lung (author's transl)].
    Matthiessen W; Pochhammer KF
    Prax Pneumol; 1976 Aug; 30(8):479-8. PubMed ID: 959156
    [No Abstract]   [Full Text] [Related]  

  • 51. High-dose intermittent iv 5-FU and melphalan in advanced colorectal carcinoma.
    Gough IR; Furnival CM
    Cancer Treat Rep; 1983 Jun; 67(6):595-6. PubMed ID: 6344994
    [No Abstract]   [Full Text] [Related]  

  • 52. Effective adjuvant treatments. A brief review of U.S. clinical trials.
    Louie AC; Rozencweig M; von Hoff DD; Muggia FM
    Arch Geschwulstforsch; 1978; 48(7):653-8. PubMed ID: 282826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Medical treatment of early breast cancer: chemotherapy].
    Ejlertsen B; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3070-2. PubMed ID: 17877950
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse effect of radiotherapy on adjuvant chemotherapy for carcinoma of the breast.
    Holland JF; Glidewell O; Cooper RG
    Surg Gynecol Obstet; 1980 Jun; 150(6):817-21. PubMed ID: 7376042
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer].
    Abe O; Izuo M; Enomoto K; Kubo K; Koyama H; Sakai K; Terasawa T; Tominaga T; Nomura Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):866-73. PubMed ID: 7184431
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
    Tanino H; Oura S; Hoffman RM; Kubota T; Furukawa T; Arimoto J; Yoshimasu T; Hirai I; Bessho T; Suzuma T; Sakurai T; Naito Y
    Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Hofmann W; Langkopf B
    Z Urol Nephrol; 1982 Dec; 75(12):889-95. PubMed ID: 6819737
    [No Abstract]   [Full Text] [Related]  

  • 58. Neoadjuvant chemotherapy for Chinese women with locally advanced breast cancer.
    Chow LW; Day W; Ng KC
    Am Surg; 2001 May; 67(5):412-6. PubMed ID: 11379638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Antineoplastic activity of combinations of cytostatics and dextran-ferrite administered to mice with leukemia P-388].
    Brusentsov NA; Glazkova TIu; Iavorskaia NP; Iurchenko NIa
    Eksp Onkol; 1990; 12(6):59-60. PubMed ID: 2261881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Comparison of adjuvant chemotherapy in breast carcinoma with a combination of cyclophosphamide, methotrexate, 5-fluorouracil (CMF) and AC (doxorubicin, cyclophosphamide). Initial results of a national cooperative study].
    Pribylová O; Petruzelka L; Honová H; Fischer J; Bustová I; Siffnerová H; Kůta M; Miller V; Hacklová M; Machácek J; Kohoutek M; Vodvárka P; Kyselá T; Tajblová J; Suk J; Dorazilová V; Bauer J
    Sb Lek; 1998; 99(1):25-31. PubMed ID: 9748796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.